~~<i id='5E7698BB68'><strike id='5E7698BB68'><tt id='5E7698BB68'><pre id='5E7698BB68'></pre></tt></strike></i>~~

Home» comprehensive» hotspot

hotspot

author：fashion 2025-09-29 03:31:04 Page View：99

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： 'Patient friction coefficient' can gauge a clinical trial's patient burden
Next article： Hollywood unions extend contract negotiations for actors

explore

Affirmative action in medical school literally saved lives

AdobeThepastseveralmonthshavebeengrimforhealthintheU.S.InDecember,theCentersforDiseaseControlandPrev

The tragedy of Johnson & Johnson’s Covid vaccine

ANorthwellHealthregisterednursefillsasyringewiththeJohnson&JohnsonCovid-19vaccineatapop-upvaccin

BioMarin wins approval for gene therapy to treat hemophilia A

AdobeTheFoodandDrugAdministrationonThursdayapprovedagenetherapytotreatpeoplewithhemophiliaA,aninheri

Texas board proposes rules on abortion law emergency exemption

MishaFriedman/GettyImagesTheTexasMedicalBoard,respondingtopressurefromthestateSupremeCourtandwidespr